Sign in
4

Changes in Ownership

Allogene Therapeutics, Inc. Filed Acc 0001209191-19-041955

President and CEO acquired 16,542 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Chang David D President and CEO 2019-06-18 Other acquisition +10,154 1,135,498 I: show line 1 in the form
Chang David D President and CEO 2019-07-10 Other acquisition +6,388 2,176,687 D: show line 2 in the form
Loading xslF345X03/doc4.xml…